Entity monitoring profile
Belmar Pharmacy Verification and Monitoring Profile
Federal 503B registration status for Belmar Pharmacy, checked against the complete FDA register, with the open fields that remain.
Belmar Pharmacy does not appear on FDA's registered outsourcing facility list, checked in full against all 96 registrations at this snapshot. That is a verified absence from the federal 503B register — not a deficiency. Compounders operating under section 503A are licensed by state boards of pharmacy and do not appear on any federal registration list.
Key findings
- Federal 503B registration: Not on the federal 503B register.
- No entry under this name appears on FDA's registered outsourcing facility list at this snapshot. That is a verified absence from the federal 503B register, not a deficiency: compounders operating under section 503A are licens
- Registration means FDA received the required filing — it is not approval and not a CGMP finding.
- No inspection outcome, Form 483, warning letter, recall or disciplinary record is verified for this entity.
- Checked against the complete FDA register of 96 outsourcing facility registrations.
| Entity name as published | Belmar Pharmacy |
|---|---|
| Federal 503B registration | No Public Evidence Found Not on the federal 503B register |
| Registered site(s) on FDA list | None under this name |
| Registry checked against | 96 registrations, FDA list, 2026-07-23 |
| Operating model | Named among 503A compounding pharmacies in telehealth supply chains. |
| State licence and number | Verification Pending |
| Nonresident licences | Verification Pending |
| FDA inspection history | Verification Pending |
| Form 483 observations | Verification Pending |
| Warning letters | Verification Pending |
| Most recent action status | Verification Pending |
| Recalls (current) | Verification Pending |
| Recalls (historical) | Verification Pending |
| State disciplinary records | Verification Pending |
| Accreditations | Verification Pending |
| Ownership | Verification Pending |
Federal registration status
No entry under this name appears on FDA's registered outsourcing facility list at this snapshot. That is a verified absence from the federal 503B register, not a deficiency: compounders operating under section 503A are licensed by state boards and do not appear on any federal registration list.
Long-established compounding pharmacy reported to work across hormone and specialty compounding alongside GLP-1 preparations.
Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA
What this means
- The full federal register was checked and the result is stated with its date.
- Absence is reported as absence from a named list, not as a finding.
- The state board holds the licence record that would complete this profile.
What this does not mean
- That this entity is compliant, safe, or non-compliant — none is asserted.
- That federal registration constitutes approval or a CGMP finding.
- That absence from this list indicates any problem — it does not.
What can and cannot be established about Belmar Pharmacy today?
Verification of a compounding entity runs across two separate systems that do not talk to each other. The federal system covers outsourcing facilities only: registration, CGMP inspection, Form 483 observations, warning letters and recalls. The state system covers licensure, scope of permitted compounding, and discipline — and it is the only system that covers 503A pharmacies at all.
For Belmar Pharmacy, the federal side is settled in the negative — it is not on the register — which means the entire evidentiary weight falls on state records that have not been captured here.
| Question | System that answers it | Status for this entity |
|---|---|---|
| Is it federally registered as a 503B facility? | FDA outsourcing facility register | No Public Evidence Found |
| Is its state pharmacy licence current? | State board of pharmacy | Verification Pending |
| Is it permitted to compound sterile preparations? | State board permit class | Verification Pending |
| Has FDA inspected it, and what was found? | FDA inspection records | Verification Pending |
| Are there Form 483 observations? | FDA inspection records | Verification Pending |
| Is there an active warning letter? | FDA warning letter database | Verification Pending |
| Any current or historical recalls? | FDA enforcement reports | Verification Pending |
| Any state disciplinary action? | State board orders | Verification Pending |
What a buyer should do with this record
This page settles one question and names the records that settle the rest. It is a starting point for verification, not a substitute for it.
If a programme names Belmar Pharmacy as its dispensing pharmacy, do not read its absence from the federal register as a problem — 503A pharmacies never appear there. Go to the state board register, which is the system that actually covers it.
What remains open for Belmar Pharmacy
With Belmar Pharmacy absent from the federal register, the entire evidentiary weight falls on state records. The board of pharmacy in its resident state holds the licence, the scope of permitted compounding, and any disciplinary history.
To determine whether a registered outsourcing facility has been the subject of a state enforcement action, FDA directs the public to check with the State Board of Pharmacy for the state in which the facility is located. FDA
The method used for each field, and why none of it can be inferred, is set out on the methodology page. Sector-level context on the gap between registration and inspection is on the monitoring hub.
- Checked against FDA's register of 96 registrations on 2026-07-23; FDA updates the list weekly.
- Self-reported registration information on FDA's list has not been verified by FDA.
- State licensure, inspection outcomes and enforcement records have not been checked for this entity.
- Sector statistics describe the 503B population, not this entity.
Sources checked for this entity — 5 sources
- FDA Registered Outsourcing Facilities listchecked 2026-07-23
- FDA — Information for Outsourcing Facilitieschecked 2026-07-23
- FDA — Q&A: Outsourcing Facility Registrationchecked 2026-07-23
- FDA — Registered Outsourcing Facilitieschecked 2026-07-23
- FDA — Aligning Federal and State Regulation of Compounderschecked 2026-07-23
Related records in this section
Section hub: Pharmacy profiles · Methodology · Status definitions · Right to respond
Frequently asked questions
Is Belmar Pharmacy a registered 503B outsourcing facility?
No. No entry under this name appears among the 96 registrations on FDA's list at this snapshot.
Does that absence indicate a problem with Belmar Pharmacy?
No. Compounders operating under section 503A are licensed by state boards of pharmacy and never appear on any federal registration list. Absence is normal and lawful.
How would I check Belmar Pharmacy's licence then?
Through the board of pharmacy in the state where it operates. State boards hold licensure and disciplinary records; FDA's register does not cover 503A pharmacies.
Is there anything specific to note about Belmar Pharmacy?
Long-established compounding pharmacy reported to work across hormone and specialty compounding alongside GLP-1 preparations.
Can Belmar Pharmacy still compound semaglutide or tirzepatide?
Both shortages are resolved and FDA proposed on 30 April 2026 to exclude both from the 503B bulks list, restricting bulk compounding by outsourcing facilities. Narrow patient-specific 503A compounding may remain available. This page assesses no entity's compliance.
Does this page allege anything about Belmar Pharmacy?
No. It reports federal register status with its source and date, and lists what remains unverified. No violation, finding, or concern is asserted.
Sources
- FDA Registered Outsourcing Facilities list
- FDA — Information for Outsourcing Facilities
- FDA — Q&A: Outsourcing Facility Registration
- FDA — Registered Outsourcing Facilities
- FDA — Aligning Federal and State Regulation of Compounders
Update history
| Date | Change |
|---|---|
| 2026-07-23 | Record published at current snapshot. |
Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.